Market Place
Sourcing Support
Alembic Pharma`s Generic Bosentan Receives Approval in U.S
25 Jan 2020 //
FDA
Alembic Pharma announces USFDA Final Approval for Bosentan Tablets
24 Jan 2020 //
EQUITYBULLS
Mylan`s Generic Bosentan Receives Approval in U.S
16 Jan 2020 //
FDA
Cipla Pharma`s Generic Bosentan Receives Approval In Us
03 Jan 2020 //
FDA
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Lupin gains as co receives USFDA approval for Bosentan tablets
02 May 2019 //
MONEY CONTROL
Lupin-Natco get USFDA nod to market generic hypertension drug
30 Apr 2019 //
MONEYCONTROL
J&J unit to pay $360 million to U.S. to resolve charity kickback probe
07 Dec 2018 //
REUTERS
FDA ‘names and shames’ generic-blocking pharma companies
17 May 2018 //
PMLIVE
Exec Reveals Sanofi (SNY) is Hunting for M&As to Boost Diabetes Biz
20 Apr 2017 //
BIOSPACE
Actelion Fails Key PhIII, but Investors Brush it off as J&J Megadeal Draws Near
24 Jan 2017 //
FIERCE PHARMA
Actelion Chief Says No Suitors Are Courting Drugmaker With Deals
22 Apr 2016 //
BLOOMBERG
Drugmaker exploit REMS to restrict generics, it doesn`t bode well for biosimilar
07 Mar 2016 //
FIERCE PHARMA
Swiss drugmaker Actelion forecasts earnings growth in 2016
09 Feb 2016 //
REUTERS
Actelion sees Uptravi price of $160,000-170,000/patient
05 Jan 2016 //
REUTERS
Actelion says selexipag to enter U.S. market in January
22 Dec 2015 //
REUTERS
With FDA nod, Actelion adds blockbuster hopeful Uptravi to PAH portfolio
22 Dec 2015 //
FIERCE PHARMA
Natco Pharma seeks next level of growth
23 Sep 2015 //
BUSINESS STANDARD
UPDATED: ZS Pharma rockets up on word of a $2.5B offer from Actelion
10 Sep 2015 //
FIERCE BIOTECH
Gilead and GSK pulmonary hypertension drugs work in tandem
28 Aug 2015 //
PM LIVE
Japan`s PAFSC to review application from Takeda on glatiramer this week
26 Aug 2015 //
FIERCE PHARMA ASIA
Actelion`s Opsumit growth heralds smooth switch off aging Tracleer
21 Jul 2015 //
FIERCE PHARMA
Actelion pours out $33M to create vaccine startup with Max Planck Society
01 Jul 2015 //
FIERCE VACCINES
Actelion creates vaccine startup with €30M investment and Max Planck assets
30 Jun 2015 //
FIERCE BIOTECH
Actelion moves MS pill into PhIII
16 Apr 2015 //
PHARMA TIMES
EMA Recommends Hundreds of Drugs to be Suspended Over "Flawed Studies"
24 Jan 2015 //
PHARMALOT
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.